122 related articles for article (PubMed ID: 3757151)
1. Evaluation of cis-diamminedichloroplatinum(II) combined with metoclopramide or sodium thiosulfate on L1210 leukemia in vitro and in vivo.
Catino JJ; Francher DM; Schurig JE
Cancer Chemother Pharmacol; 1986; 18(1):1-4. PubMed ID: 3757151
[TBL] [Abstract][Full Text] [Related]
2. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.
Howell SB; Taetle R
Cancer Treat Rep; 1980; 64(4-5):611-6. PubMed ID: 7191778
[TBL] [Abstract][Full Text] [Related]
3. Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.
Aamdal S; Fodstad O; Pihl A
Cancer Chemother Pharmacol; 1988; 21(2):129-33. PubMed ID: 3349560
[TBL] [Abstract][Full Text] [Related]
4. In vivo potentiation of cis-diamminedichloroplatinum (II) antitumor activity by pretreatment with sparsomycin.
Zylicz Z; Wagener DJ; van Rennes H; Wessels JM; van der Kleijn E; de Grip WJ; Ottenheijm HC; van den Broek LA
Cancer Lett; 1986 Jul; 32(1):53-9. PubMed ID: 3742487
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclones.
Hofs HP; Wagener DJ; de Valk-Bakker V; van Rennes H; van Zeist AJ; van den Broek LA; Ottenheijm HC
Cancer Chemother Pharmacol; 1993; 31(4):289-94. PubMed ID: 8422692
[TBL] [Abstract][Full Text] [Related]
6. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
7. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
Potemski P; Polakowski P
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine.
Rauko P; Novotny L; Dovinova I; Hunakova L; Szekeres T; Jayaram HN
Eur J Pharm Sci; 2001 Feb; 12(4):387-94. PubMed ID: 11231105
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemia.
Hofs HP; Wagener DJ; De Valk-Bakker V; Van Rennes H; Van Zeist AJ; Van Den Broek LA; Ottenheijm HC
Anticancer Res; 1992; 12(1):167-70. PubMed ID: 1567164
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of cis-diamminedichloroplatinum (II) in blood by sodium thiosulfate.
Abe R; Akiyoshi T; Baba T
Oncology; 1990; 47(1):65-9. PubMed ID: 2300388
[TBL] [Abstract][Full Text] [Related]
13. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.
Poirier MC; Lippard SJ; Zwelling LA; Ushay HM; Kerrigan D; Thill CC; Santella RM; Grunberger D; Yuspa SH
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6443-7. PubMed ID: 6959129
[TBL] [Abstract][Full Text] [Related]
14. [Systemic chemotherapy with cisplatin and sodium thiosulfate (STS) rescue--its effect on the antitumor activity of cisplatin and the total platinum concentration in tumor bearing nude mice].
Lee KE; Sawamura M; Ishibashi A; Koshiba K; Kubota T; Kawamura E
Nihon Gan Chiryo Gakkai Shi; 1986 Apr; 21(3):601-8. PubMed ID: 3734533
[No Abstract] [Full Text] [Related]
15. Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
Han XJ; Shi SL; Wei YF; Jiang LP; Guo MY; Wu HL; Wan YY
Oncol Rep; 2017 Aug; 38(2):985-992. PubMed ID: 28677814
[TBL] [Abstract][Full Text] [Related]
16. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
Fujimoto S
Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
[TBL] [Abstract][Full Text] [Related]
20. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
